Rheumatology education

By : Global Rheumatology by PANLAR
25 January, 2021
https://doi.org/10.46856/grp.232.e061
views 399Views

License

This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.

To become a rheumatologist a physician must complete a prolonged training period formally defined in most of our countries, this phase is known as medical residency (3 to 5 years), fellowship or medical-surgical specialization, which also reflects, to some extent, the varied training realities of the different countries. For instance, the requirement for a first specialty such as internal medicine or pediatrics, or the type of accreditation a rheumatologist may require at the end of his or her training from a scientific society, to cite a few examples. 

Learning about rheumatology education experiences, as well as what success factors can be identified in postgraduate training in our area, are topics we will cover  today in this episode dedicated to the training of rheumatologists in A coffee for rheumatology.

Carlo Vinicio Caballero, editor in chief of Global Rheumatology and Diego Jaimes, will be joined by Eduardo Durante, physician, director of the Master program on education for health professionals at the Hospital Italiano de Buenos Aires and Carlos Lozada, rheumatologist, president of PANLAR and director of the rheumatology program at the University of Miami Miller School of Medicine

More podcast

Empowered patient, a new approach in rheumatology

A patient-centered care and an informed and confident patient are key elements for better…

World Arthritis Day

Since 1996, October 12th is recognized as World Arthritis Day.

New Way of Treating Patients

Discuss how the clinic responded to the need to evaluate patients in non-presential environments…

Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.

As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges…

enviar Envía un artículo